NOVOCURE LTD (NVCR)
JE00BYSS4X48 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 17.63M | 9.96M | 9.70M | 3.10M | 20.30M | |||
| Cash Equivalents | 412.93M | 227.17M | 105.60M | 205.70M | 214.30M | |||
| Marketable Securities | 439.59M | 673.50M | 854.10M | 728.90M | 607.90M | |||
| Receivables | 86.57M | 71.85M | 106.00M | 110.60M | 100.60M | |||
| Inventories | 42.39M | 38.15M | 29.40M | 24.40M | 27.40M | |||
| Other Current Assets | 3.60M | 13.79M | 6.70M | 800.00K | 28.80M | |||
| Total Current Assets | 1.00B | 1.03B | 1.11B | 1.07B | 999.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 103.82M | 97.70M | 69.00M | 53.90M | 41.60M | |||
| Other Non-Current Assets | 14.90M | 14.02M | 11.20M | 12.10M | 10.90M | |||
| Total Non-Current Assets | 118.72M | 111.72M | 80.10M | 66.00M | 52.60M | |||
| TOTAL ASSETS | 1.12B | 1.15B | 1.19B | 1.14B | 1.05B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | N/A | 59.27M | 46.60M | 46.30M | 30.30M | |||
| Accounts Payable | 84.32M | 94.39M | 85.20M | 72.60M | 53.60M | |||
| Other Current Liabilities | 75.91M | 25.46M | 27.00M | 23.70M | 29.60M | |||
| Total Current Liabilities | 160.23M | 179.12M | 158.80M | 142.60M | 113.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 569.65M | 568.82M | 565.50M | 562.20M | 429.90M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 32.19M | 35.70M | 26.20M | 24.20M | 31.90M | |||
| Total Non-Current Liabilities | 601.84M | 604.52M | 591.70M | 586.40M | 461.90M | |||
| TOTAL LIABILITIES | 762.07M | 783.63M | 750.50M | 729.00M | 575.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.02B | -985.50M | -778.50M | -685.90M | -631.10M | |||
| Additional Paid In Capital | 1.39B | 1.35B | 1.22B | 1.10B | 1.11B | |||
| Common Shares | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -4.15M | -5.47M | -2.40M | -3.20M | -3.80M | |||
| Shares Outstanding | 107.60M | 107.08M | 105.00M | 104.00M | 102.30M | |||
| Tangible Book Value per Share | 3.34 | 3.39 | 4.20 | 3.95 | 4.66 | |||
| Total Shareholders' Equity | 359.36M | 362.50M | 441.20M | 410.50M | 476.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.12B | 1.15B | 1.19B | 1.14B | 1.05B | |||
| Statistics | ||||||||
| Debt/Equity | 1.59 | 1.57 | 1.28 | 1.37 | 0.90 | |||
| Current Ratio | 6.26 | 5.78 | 7.00 | 7.53 | 8.80 | |||
| Return On Assets (ROA) | -17.19% | -18.06% | -7.76% | -5.13% | 1.88% | |||
| Return On Equity (ROE) | -53.63% | -57.12% | -20.97% | -14.23% | 4.16% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 2.56% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 20.67% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 20.67% | |||
All data in USD